» Articles » PMID: 34641292

Synthesis, In Vitro, and In Silico Analysis of the Antioxidative Activity of Dapsone Imine Derivatives

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Oct 13
PMID 34641292
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Dapsone (DDS) is an antibacterial drug with well-known antioxidant properties. However, the antioxidant behavior of its derivatives has not been well explored. In the present work, the antioxidant activity of 10 dapsone derivatives 4-substituted was determined by an evaluation in two in vitro models (DPPH radical scavenging assay and ferric reducing antioxidant power). These imine derivatives - were obtained through condensation between DDS and the corresponding aromatic aldehydes 4-substuited. Three derivatives presented better results than DDS in the determination of DPPH (, , and ). Likewise, we have three compounds with better reducing activity than dapsone (, , and ). In order to be more insight, the redox process, a conceptual DFT analysis was carried out. Molecular descriptors such as electronic distribution, the total charge accepting/donating capacity (I/A), and the partial charge accepting/donating capacity (ω/ω) were calculated to analyze the relative donor-acceptor capacity through employing a donor acceptor map (DAM). The DFT calculation allowed us to establish a relationship between GAP and DAM with the observed antioxidant effects. According to the results, we concluded that compounds and have the lowest values, representing a good antioxidant behavior observed experimentally in DPPH radical capturing. On the other hand, derivatives , , and display the best reducing capacity activity with the highest ω and values. Consequently, we propose these compounds as the best antireductants in our DDS imine derivative series.

Citing Articles

Antioxidant capacity of simplified oxygen heterocycles and proposed derivatives by theoretical calculations.

Borges R, Aguiar C, Oliveira N, Amaral I, Vale J, Chaves Neto A J Mol Model. 2023; 29(8):232.

PMID: 37407749 DOI: 10.1007/s00894-023-05602-8.

References
1.
Derouin F, Piketty C, Chastang C, Chau F, Rouveix B, Pocidalo J . Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine. Antimicrob Agents Chemother. 1991; 35(2):252-5. PMC: 244986. DOI: 10.1128/AAC.35.2.252. View

2.
Yehye W, Rahman N, Ariffin A, Hamid S, Alhadi A, Kadir F . Understanding the chemistry behind the antioxidant activities of butylated hydroxytoluene (BHT): a review. Eur J Med Chem. 2015; 101:295-312. DOI: 10.1016/j.ejmech.2015.06.026. View

3.
Lagunin A, Dubovskaja V, Rudik A, Pogodin P, Druzhilovskiy D, Gloriozova T . CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds. PLoS One. 2018; 13(1):e0191838. PMC: 5784992. DOI: 10.1371/journal.pone.0191838. View

4.
Diaz-Ruiz A, Zavala C, Montes S, Ortiz-Plata A, Salgado-Ceballos H, Orozco-Suarez S . Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats. J Neurosci Res. 2008; 86(15):3410-9. DOI: 10.1002/jnr.21775. View

5.
Wozel G, Blasum C . Dapsone in dermatology and beyond. Arch Dermatol Res. 2013; 306(2):103-24. PMC: 3927068. DOI: 10.1007/s00403-013-1409-7. View